VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 11, 2013) -


Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CNSX:PDH) is pleased to announce that a Letter of Intent (LOI) between Premier and a Chinese Conglomerate has recently been signed by both parties. The LOI defines the relationship, the responsibilities of each party and the scope of the project(s) to be undertaken by this Sino Canadian Joint Venture.

In this regard, the initial project will involve the planning, design, implementation and operation of a freestanding, state of the art medical diagnostic center in a major population center in China, identified as a Sino Canadian Joint Venture and branded as a "Center for Advanced Diagnostics." It is anticipated that up to 30 such Centers will be built in the next five years.

These "Super Centers" will be equipped with the latest technologies including PET/CT, MRI, testing for communicable diseases, and rehabilitation capabilities.

According to the terms of the LOI, the China partner will provide the necessary funding and take the lead in procuring the necessary licenses for this advanced facility. Premier will oversee the physical aspects of planning, equipping, training, and operating this "Center for Advanced Diagnostics."

"The nature of this relationship and the common vision for a healthier future for the people of China gives me great confidence in the ultimate success of this undertaking," said Denis Tusar, President and CEO of Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

PHD is a Canadian company that provides advanced medical diagnostic tools utilizing of PET/CT Technology and/or MRI Technology and related diagnostic skills in Canada and, in partnership with hospitals and clinics in the People's Republic of China. The company's vision is to provide services and that support "improving medical decisions" around the world. The company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' and Clinics' diagnostic capacity and capability.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release. Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier. (Not for dissemination in the United States of America).

Contact Information:

Premier Diagnostic Health Services Inc.
Denis Tusar
President & CEO
(604) 678.9120 Ext. 225
(604) 678.9278 (FAX)

Premier Diagnostic Health Services Inc.
Daniel Waters
Investor Relations
(604) 678.9120 Ext. 236
(604) 678.9278 (FAX)